0001567619-21-014770.txt : 20210809
0001567619-21-014770.hdr.sgml : 20210809
20210809170136
ACCESSION NUMBER: 0001567619-21-014770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210805
FILED AS OF DATE: 20210809
DATE AS OF CHANGE: 20210809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STONEPINE CAPITAL, L.P.
CENTRAL INDEX KEY: 0001370042
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37500
FILM NUMBER: 211157318
BUSINESS ADDRESS:
STREET 1: 919 NW BOND STREET
STREET 2: SUITE 204
CITY: BEND
STATE: OR
ZIP: 97703
BUSINESS PHONE: 541-647-5664
MAIL ADDRESS:
STREET 1: 919 NW BOND STREET
STREET 2: SUITE 204
CITY: BEND
STATE: OR
ZIP: 97703
FORMER NAME:
FORMER CONFORMED NAME: STONEPINE CAPITAL L P
DATE OF NAME CHANGE: 20060724
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIASMA, INC
CENTRAL INDEX KEY: 0001339469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 KENDRICK STREET
STREET 2: BUILDING C EAST
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 617-928-5300
MAIL ADDRESS:
STREET 1: 140 KENDRICK STREET
STREET 2: BUILDING C EAST
CITY: NEEDHAM
STATE: MA
ZIP: 02494
FORMER COMPANY:
FORMER CONFORMED NAME: CHIASMA INC
DATE OF NAME CHANGE: 20050922
4
1
doc1.xml
FORM 4
X0306
4
2021-08-05
1
0001339469
CHIASMA, INC
CHMA
0001370042
STONEPINE CAPITAL, L.P.
919 NW BOND STREET, SUITE 204
BEND
OR
97703
0
0
1
0
Common Stock
2021-08-05
4
D
0
6770000
D
0
I
See Footnote
The filers are Stonepine Capital Management, LLC ("Stonepine"), Stonepine Capital, L.P. (the Partnership"), Jon M. Plexico and Timothy P. Lynch. Stonepine is the general partner and investment adviser of the Partnership. Mr. Plexico and Mr. Lynch are Stonepine's managers and control persons. These securities are held directly by the Partnership for the benefit of its investors and are indirectly beneficially owned by Stonepine, as the general partner and investment adviser of the Partnership, and by Mr. Plexico and Mr. Lynch, as Stonepine's control persons. Stonepine is filing this Form 4 for itself and the other filers. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each filer disclaims beneficial ownership of these securities except to the extent of that filer's pecuniary interest therein.
This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated as of May 4, 2021, by and among Chiasma, Inc. (the "Company), Amryt Pharma plc ("Parent"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent ("Merger Sub") pursuant to which Merger Sub merged with and into the Company (the "Merger") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August 5, 2021 (the "Effective Time"). At the Effective Time, each share of common stock of the Company (each, a "Share") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 American Depositary Shares of Parent representing five ordinary shares of Parent.
Stonepine Capital, L.P., by Timothy P. Lynch, Manager of its General Partner
2021-08-09